Physicians' Academy for Cardiovascular Education
Modern management of diabetes in cardiology:  Impact of SGLT2 inhibition on cardiovascular outcomes and heart failure

Modern management of diabetes in cardiology: Impact of SGLT2 inhibition on cardiovascular outcomes and heart failure

Aug. 28, 2017 - ESC, Barcelona, Spain

Monday, August 28, 2017

Agenda

The Educational objectives are to:

CME Accreditation

This programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME®) and EBAC have recognized each other’s accreditation systems as substantially equivalent.

In compliance with EBAC guidelines, all speakers/Chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities

Funding

Supported by an unrestricted educational grant from Boehringer Ingelheim/Lilly.

Register

Please pre-register if you wish to attend the symposium. All participants should be registered for the ESC 2017 congress via the ESC

Register for symposium